Arginine methyltransferase inhibitors and uses thereof
US9765035B2 · kind B2 · utility
15Cited by
37References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | May 2, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.